Medicinal product licensing
The company provides licensing-in and licensing-out services for medicinal products.
Source: LinkedIn company description · Retrieved October 13, 2026
Imfarm is a consulting agency specializing in the development of value-added generics, from formulation through registration strategy and market access.
The company creates and executes market-access strategies for prescription and over-the-counter medicines, medical devices, and food supplements in CEE and CIS countries.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company recruits managers and senior managers, including country managers, for pharmaceutical and medical-device companies in Poland, CEE and CIS.
The company provides licensing-in and licensing-out services for medicinal products.
Source: LinkedIn company description · Retrieved October 13, 2026
The company creates, recruits, and manages sales forces for pharmaceutical and medical-device businesses in Poland and CEE and CIS countries.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 1, 2026, September 2, 2026, September 4, 2026, September 11, 2026, September 14, 2026, September 16, 2026, September 19, 2026, September 20, 2026, September 26, 2026, September 27, 2026, September 28, 2026, September 29, 2026, September 30, 2026, October 7, 2026, October 8, 2026, October 9, 2026 and October 10, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.